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Fig.1 A Initial computed tomography after the previous head injury shows the fracture of 
the sphenoid sinus b lack  ar row and a small associated intrasinusoidal hematoma. B Con- 
ventional tomography demonstrates the large right sided skull fracture, particularly the 
fracture of the frontal sinus wall b lack  ar row 
The present case is of particular interest 
because of the spontaneous remission of 
the CSF rhinorrhea fter SHT without he 
occurrence ofmeningitis over the following 
years. Delayed complications (meningitis 
or CSF rhinorrhea) from ethmoid or skull 
base fractures are known to occur months 
or years after the initial trauma, with an in- 
cidence of 9.3 to 36 % [2], but an onset after 
more than 10 years without any neurologi- 
cal complaints i extremely rare. The 
mechanism of reopening the fistula in the 
present case may have been due to the de- 
livery with the transient elevated intracra- 
nial pressure and the consequent change in 
brain tissue or meningeal compliance [3]. 
Surgical occlusion of the frontobasal dural 
leak, if performed after the initially report- 
ed rhinorrhea several years before, could 
have prevented this patient from experi- 
encing the delayed reopening of the fistula 
under elevated intracranial pressure. 
With the availability of different nonin- 
vasive imaging techniques, which allow an 
accurate localization of the dural leak, such 
as coronal high-resolution computed to- 
mography (HR-CT) [4], magnetic reso- 
nance imaging (MRI), and provoking 
positional MRI [5], the present case em- 
phasizes the need for a standardized diag- 
nostic protocol. For example, after 
spontaneous remission of CSF rhinorrhea 
the dural esion should be identified, first 
by HR-CT, and, if negative, by MRI, and 
finally by provoking positional MRI. De- 
tailed diagnosis combined with new meth- 
ods in microsurgical techniques with their 
known low surgical mortality and morbidi- 
ty may lower restraints against (neuro-) 
surgical procedures. Therefore, surgical 
occlusion of the dural leak should be con- 
sidered even after spontaneous remission 
of the CSF rhinorrhea. 
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Sir: Neuromuscular complications in inten- 
sive care patients [1] are mainly the critical 
illness polyneuropathy [2]and the acute 
myopathy that follows administration f 
neuromuscular blocking agents (NMBA) 
and corticosteroids (CS) [3]. 
We report a 48-year-old woman suffer- 
ing from chronic obstructive pulmonary 
disease who was hospitalized twice for 
acute respiratory failure over an 18-month 
period. On the first admission, she receiv- 
ed etomidate 20mg, fentanyl 75 mg, and 
succinyleholine (SCh) 100 mg for initiation 
of mechanical ventilation. Sedation con- 
sisted of midazolam and morphine. Severe 
bronchoconstriction f llowed despite the 
administration f intravenous salbutamol 
up to 20 ~tg/min and prednisolone 300 mg/ 
day (total dose 4800 mg) before extuba- 
tion). Pancuronium was also administered 
(total dose 130 mg over 48 h). Mechanical 
ventilation was required for 19 days, during 
which there were no signs of renal failure, 
septic shock, or multiple organ dysfunction. 
Creatine kinase (CK) levels rose from nor- 
mal values on admission to 1000 U/1 (nor- 
mal 25-140 U/l) during the first 48 h, then 
decreased to normal over 23 days. After 
extubation, symmetrical quadriparesia was 
present, without sensory deficit. Nerve 
conduction studies revealed normal senso- 
ry nerve conduction and a marked ecrease 
in the amplitude of the compound muscle 
action potentials and electromyography 
showed diffuse fibrillation potentials. The 
patient recovered normal strength over a 
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3-month period. Eighteen months later, 
she was admitted for the same symptoms. 
Prednisolone (total dose 4725 mg before 
extubation), etomidate 20 mg, and SCh 
150 mg were administered. Pancuronium 
was not given. A transient elevation of 
CK (280 U/l) was noted on the 3rd day. She 
was extubated after 11 days. Again, quad- 
riparesia was present, associated with iden- 
tical electrophysiologic f ndings. Needle 
muscles biopsies revealed fiber anisometry, 
atrophy, necrosis, and myophagism. The 
patient recovered normal strength over a 
2-month period. 
This patient presented two episodes of 
severe quadriparesia, increased CK, elec- 
trophysiologic signs of myopathy, and his- 
tologic myopathic hanges. These findings 
are those of an acute intensive care myop- 
athy that follows administration of NMBA 
and CS [3], different from those of poly- 
neuropathy in critical illness [2]. Even if 
such polyneuropathy can present with pure 
motor axonal degeneration, recuperation 
was too rapid in this patient o be compati- 
ble with motor axonal degeneration. The 
first episode can be attributed to both pan- 
curonium and CS. The second is possibly 
due to CS. However, the causative role of 
CS alone may be questioned. The first de- 
scription of acute CS myopathy is attrib- 
uted to MacFarlane and Rosenthal [4], but 
their patient, as most other cases reported 
in the literature, received both CS and 
pancuroninm. Moreover, acute CS myopa- 
thy never follows high doses of CS given in 
other conditions, such as treatment of mul- 
tiple sclerosis or spinal trauma. Thus, acute 
CS myopathy is probably extremely rare. 
Alternative xplanations for the second 
episode are: (1) a role for SCh alone, as 
suggested by Karoubi et al. [5], or in con- 
junction with CS, (2) sensitization of the 
muscle to the toxic effect of CS following 
the first episode, (3) another unknown 
factor in relation to respiratory failure, 
such as hypoxia or systemic inflammatory 
response. 
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